MarketResearchReports.com: U.S. Market for Gynecological Devices, New Report Launched

This report covers assisted reproduction, global endometrial ablation, uterine fibroid embolization, hysteroscopes, colposcopes, female sterilization, female urinary incontinence slings, pelvic floor electrical stimulation, endometrial resection, fluid management, pelvic organ prolapse repair and hysterosalpingography (HSG) catheters.

After seeing a decline in 2011 and 2012, as a result of the global financial crisis, this market is expected to recover in 2013. The majority of the segments within this market will see steady and stable growth over the forecast period.

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment & Country
• Trend Analysis by Segment & Country
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Markets Included:

• Assisted Reproduction Devices
• Global Endometrial Ablation
• Endometrial Resection Devices
• Uterine Fibroid Embolization Devices
• Hysteroscopes
• Colposcopes
• Female Sterilization Devices
• Female Urinary Incontinence Slings
• Pelvic Floor Electrical Stimulation Devices
• Fluid Management Equipment
• Pelvic Organ Prolapse Repair Devices
• HSG Catheters

Sub-Segments Included:

• Oocyte Retrieval Needles
• Micropipettes
• Embryo Transfer Catheters
• Reproduction Media
• Manipulation Media
• Uterine Balloon Therapy
• Hydrothermal Ablation
• Radiofrequency Ablation
• Cryoablation
• Microwave Ablation
• Monopolar Electrodes
• Bipolar Electrodes
• Resectoscope
• Uterine Fibroid Embolization Devices
• Microsphere
• PVA Particle
• Rigid and Flexible Hysteroscopes
• Mechanical Sterilization Devices
• Bipolar Sterilization Devices
• Synthetic and Non-Synthetic Slkings
• Home-based and Office-based pelvic Floor Electrical Stimulation Devices
• Capital Equipment
• Tubing
• Transvaginal Mesh
• Sacrocolpopexy Mesh

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Spanning over 301 pages, “U.S. Market for Gynecological Devices” report Includes U.S. Market For Gynecological Devices, Assisted Reproduction Device Market, Global Endometrial Ablation Market, Endometrial Resection Device Market, Uterine Fibroid Embolization Device Market, Hysteroscope Market, Colposcope Market, Female Sterilization Device Market, Female Urinary Incontinence Sling Market, Pelvic Floor Electrical Stimulation Device Market, Fluid Management Equipment Market, Pelvic Organ Prolapse Repair Device Market, HSG Catheter Market.

The report cover 37 Companies, few are Uroplasty, Hologic, Johnson & Johnson, Conceptus, Karl Storz, SRS Medical, Prometheus, Richard Wolf, Merit Medical Systems, Cooper Surgical, Coloplast, Laborie Medical, American Medical Systems, Boston Scientific, Cook Medical, Irvine Scientific, Empi, Welch Allyn, C.R. Bard, Uromed.

For more information visit: http://www.marketresearchreports.com/idata-research/us-market-gynecological-devices

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: U.S. Market for Dental Imaging Devices, New Report Launched

A rapidly rising number of GPs offering implant treatment continues to drive the dental implant and final abutment market towards historic growth rates.

In 2012, the total U.S. market for dental implants and final abutments was valued at nearly $979 million. This market includes dental implants, final abutments, dental implant instrument kits and computer guided surgery products. The market is expected to maintain moderate growth rates as the number of dental implant procedures continues to rise, facilitated by the increasing number of dental professionals offering the procedures. Furthermore, implant manufacturers are increasingly bolstering sales of their restorative offerings through supportive technology such as bone graft substitutes and CAD/CAM technology.

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment & Country
• Trend Analysis by Segment & Country
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Segmentation:

• U.S. Dental Implant And Final Abutment Market
• Dental Implant Market
• Dental Implant End Users
• Dental Implants by Procedure Type
• Dental Implants by Shape
• Dental Implants by Connection Type
• Final Abutment Market
• Dental Implant Instrument Kit Market
• Computer Guided Surgery Market

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Spanning over 166 pages, “U.S. Market for Dental Imaging Devices” report includes U.S. Dental Imaging Device Market Overview, Dental X-Ray Procedures, Intraoral X-Ray Device Market, Extraoral X-Ray Device Market, Cone Beam Computed Tomography Scanner Market, and Dental Camera Market.

The report cover 34 Companies, few are BIOMET 3i, Zimmer Dental, Implant Direct, BioHorizons, MIS Implants, Nobel Biocare, Straumann, DENTSPLY Implants.

For more information visit: http://www.marketresearchreports.com/idata-research/us-market-dental-imaging-devices

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: Japanese Marktet for Neurovascular Devices, New Report Launched

In 2012, the Japanese market for neurological devices was valued at nearly $553 million.

The Japanese market for neurological devices includes bare platinum coils, coated coils, liquid embolics, neurovascular stents, neurovascular catheters, neurovascular guidewires, deep brain stimulators, spinal cord stimulators, sacral nerve stimulators, intrathecal pumps, frame-based stereotactic systems, frameless stereotactic systems and aneurysm clips. The growth in this market will be driven by the rapidly growing aging population in Japan and the increased demand and acceptance of endovascular cerebral aneurysm repairs.

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for Japan.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment & Country
• Trend Analysis by Segment & Country
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Segments Included:

• Detachable Coils Market
• Liquid Embolics Market
• Neurovascular Stent Market
• Neurovascular Catheter Market
• Neurovascular Guidewire Market
• Neuromodulation Device Market
• Stereotactic System Market
• Aneurysm Clip Market

Sub-Segments Included:

• Over-the Wire Neurovascular Catheter Market
• Flow Directed Neurovascular Catheter Market
• Deep Brain Stimulator, Spinal Cord Stimulator, Gastric Electric Stimulator, Sacral Nerve Stimulator
• Intrathecal Pumps
• Vagus Nerve Stimulators
• Frame-based Stereotactic Market
• Frame-less Stereotactic System
• Hydrocephalus
• Cerebral Edema

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Spanning over 76 pages, “Japanese Marktet for Neurovascular Devices” report includes Japanese Neurovascular Device Market, Currency Exchange Rates, Market Overview, Market Analysis And Forecast, Market Drivers And Limiters, Competitive Analysis.

For more information visit: http://www.marketresearchreports.com/idata-research/japanese-marktet-neurovascular-devices

Find all Medical devices reports under a single page

MarketResearchReports.com: Canadian Market for Dental Prosthetics and CAD/CAM Devices, New Report Launched

In 2012, the Canadian market for dental prosthetics was valued at nearly $2.4 billion and is expected to grow over the forecast period.

The Canadian market for dental prosthetics includes crowns, bridges, inlays and onlays, veneers, and dentures. In 2012, the crown and denture markets were the two fastest growing segments, while growth slowed in the veneer market. The fastest growing laboratories where those specialized in high-end cosmetic restorations. Smaller laboratories focused on lower-end devices engaged in aggressive price competition, leading some laboratories to close their doors.

The total dental prosthetics market is expected to experience modest growth over the next several years. Nearing the end of the forecast period, growth is expected to increase due to the aging population.

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for Canada.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment & Country
• Trend Analysis by Segment & Country
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Segments Included:

• Crown And Bridge Market
• Inlay And Onlay Market
• Veneer Market
• Denture Market
• CAD/CAM  System Market
• CAD/CAM Blocks And Prosthetics Market
• Clinical CAD/CAM System Market
• Rapid Prototyping System Market

Spanning over 258 pages, “Canadian Market for Dental Prosthetics and CAD/CAM Devices” report includes Dental Prosthetics Market Overview, Crown and Bridge Market, Inlay and Onlay Market, Veneer Market, Denture Market, Laboratory CAD/CAM System Market, Clinical CAD/CAM System Market, CAD/CAM Block and Prosthetic Market, Rapid Prototyping System Market, Leading Competitors in the Market for Automated Prosthetics.

The report cover 29 Companies - 3M ESPE, 3Shape, Align Technologies, AmannGirrbach, Candulor, D4D Technologies, Dental Wings, Dentorium, DENTSPLY, Heraeus Kulzer, imes-icore, Ivoclar Vivadent, Myerson, Nobel Biocare, Roland, Ruthinium, Sirona, Tiziano, Vident, Wieland Dental, Yamahachi Dental, Zirkonzahn, VITA, Wieland Dental, Diadem Precision Technology, Glidewell Laboratories, 3D Systems, EnvisionTEC, Stratasys.

For more information visit: http://www.marketresearchreports.com/idata-research/canadian-market-dental-prosthetics-and-cadcam-devices

Find all Dental market research reports under a single page

European Orthopedic Biomaterials Market is expected to reach € 376.7 Million by 2019, revels new report

The European orthopedic biomaterials market is expected to reach €376.7 million by 2019, with hyaluronic acid viscosupplementation as the largest segment.

The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantation (ACI).

As the market continued to recover from the economic crisis, slow growth was often seen across different regions. The ACI market underwent drastic changes in 2012 due to modifications in the European Medicines Agency (EMA) regulations.

While autografts were still commonly used in 2012, easy accessibility and price declines have made bone graft substitute products an attractive option. Surgeons and patients alike have become increasingly interested in minimally invasive procedures, which greatly decrease the pain associated with bone graft procedures.

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for:

Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment & Country
• Trend Analysis by Segment & Country
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Segments Included:

• Bone Graft Substitute Market
• Allograft Bone Graft Substitute Market
• Synthetic Bone Graft Substitute Market
• Demineralized Bone Matrix Bone Graft Substitute Market
• Hyaluronic Acid Viscosupplementation Market
• Bone Morphogenetic Protein Growth Factor Market
• Autologous Chondrocyte Implantation Market

Sub-Segments Included:

• Allograft Cervical Spine Market
• Allograft Thoracolumbar Spine Market
• Allograft Trauma and Reconstruction Market
• Allograft Craniomaxillofacial Market
• Synthetic Cervical Spine Market
• Synthetic Thoracolumbar Spine Market
• Synthetic Trauma and Reconstruction Market
• Synthetic Craniomaxillofacial Market
• Cervical Spine Demineralized Bone Matrix Market
• Thoracolumbar Spine Demineralized Bone Matrix Market
• Trauma and Reconstruction Demineralized Bone Matrix Market
• Craniomaxillofacial Demineralized Bone Matrix Market

Spanning over 328 pages, “European Markets for Orthopedic Biomaterials” report includes European Orthopedic Biomaterials Market, Country Profiles, Bone Graft Substitute Market, Hyaluronic Acid Viscosupplementation Market, Bone Morphogenetic Protein Growth Factor Therapy Market, Autologous Chondrocyte Implantation Market. The report covers 34 companies; few are DePuy SynthesOlympus, Zimmer, Wright Medical, Smith & Nephew, RottaPharm, Fidia, Genzyme, Medtronic, TRB Chemedica, Laboratoire Genevrier, Stryker, RTI Biologics, Biomet, Croma-Pharma, TiGenix, Fin-Ceramica, Tedec-Meiji, Seikagaku.

For more information visit: http://www.marketresearchreports.com/idata-research/european-markets-orthopedic-biomaterials

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019, New Report Launched

There is currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high blood glucose. The market is led by Lantus, which achieved global sales amounting to $6.4 billion in 2012.

Over the forecast period from 2012 to 2019, the safer, more efficacious newer classes of drug (GLP-1 agonists, DPP-4 Inhibitors and SGLT-2 inhibitors) are expected to capture substantial market shares, largely replacing older classes such as sulfonylureas and thiazolidinediones. Additionally, a variety of novel drugs belonging to these newer classes are due to enter the market, and are expected to offer a moderate improvement in terms of efficacy and safety. The price of these new therapies is expected to be high, but this is unlikely to hinder their uptake. As a result, as well as an overall increase in the prevalent population, publisher believes that the value of the global market has the potential to grow to reach $38.8 billion by 2019.

Scope

• A brief introduction to type 2 diabetes, including the symptoms, pathogenesis, risk factors and diagnosis
• Includes a heat map comparing major drugs in terms of safety, efficacy and dosing parameters.
• Comprehensive review of the pipeline for type 2 diabetes therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period. The pipeline is analyzed on the basis of phase distribution, molecule types and molecular targets.
• Additional in-depth analysis of pipeline drug clinical trials by phase, molecule type, trial size, trial duration and program failure rate analyses for each molecule type and mechanism of action
• Multi-scenario forecast data for the market up to 2019, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs, and changes in disease epidemiology across key developed markets including the US, Japan, Germany, the UK, France, Italy and Spain
• Discussion of the drivers and barriers for market growth

Reasons to buy

• Understand the many different types of type 2 diabetes therapies on the market, from the older, established classes of treatment to newer, moderately superior types of drug, and their positions in the treatment algorithm
• Understand the strengths and weaknesses of each product
• Understand the scope of the pipeline, including which molecule types and mechanisms of action are prominent
• Observe trends in clinical trial duration and size amongst clinical phases and molecule types, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for type 2 diabetes therapeutics
• Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the type 2 diabetes therapeutics market.

Spanning over 125 pages, 16 tables and 40 figures “Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019” report provide in-depth analysis of major glucose-lowering drugs for type 2 diabetes, including analyses of their safety, efficacy, treatment patterns, strengths/weaknesses and overall commercial prospects.

In addition to covering the Key Marketed Products, Pipeline for Type 2 Diabetes, Market Forecast to 2019, Deals and Strategic Consolidations.

For more information visit: http://www.marketresearchreports.com/gbi-research/type-2-diabetes-therapeutics-market-2019-shifting-treatment-algorithm-and-intensified

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: Asthma Therapeutics Market is forecast to a projected value of $21.6 billion in 2019, Reveals New Report

The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019. This growth is expected despite the generic erosion facing the leading brands, and is a consequence of new market entrants and a disease prevalence that continues to rise, albeit not at rates as high as have been seen in the past.

Some new, costly asthma therapies could be set to enter the asthma market, including GlaxoSmithKline’s (GSK’s) recently approved Relvar (fluticasone/vilanterol), and multiple monoclonal antibodies (mAbs). These include reslizumab, mepolizumab and lebrikizumab, which are being developed by Teva, GSK and Roche respectively.

The mAbs, in particular, have the potential to change the asthma treatment landscape, most notably with regards to severe forms of the disease. Although such therapy may only play the role of an alternative treatment in the asthma treatment algorithm, their ability to reduce exacerbation rates has strong clinical and commercial value.

The report assesses the current asthma market, and forecasts market trends to 2019, analyzing key drivers and barriers. The areas covered include the following:-

• A disease introduction, which defines the disease, including symptoms, diagnosis and treatment
• Analysis of the landscape of the asthma market, including a comparison of the efficacy and safety of the most prominent brands.
• An in-depth forecasting model for the asthma market, which considers the current marketed therapies, in addition to the potential market entry of new products. The model consists of a projected outcome, with high and low variance results, depending on the potential performance of pipeline therapies.
• Analysis of strategic consolidations within the asthma indication, including co-development and licensing agreements
• An overview of the drivers and barriers for the asthma market

Reasons to buy

Primarily, the report will enable clients to establish a strong understanding of the asthma indication, helping to identify and understand market opportunities and the emerging competitive environment. It will also enable you to:-

• Understand the asthma pipeline and the factors that indicate that it is becoming more innovative. This is highlighted by the presence of numerous biologics in the pipeline, which look set to have a major impact upon the asthma market.
• Observe detailed profiles for promising pipeline products, including revenue forecasts, and gain insights into how they are likely to compete in the market and who their main competitors will be.
• Follow the trends in asthma clinical trial size and duration in relation to industry averages. In addition, the report will enable you to assess the potential risk of future developmental programs for asthma therapeutics, depending on the mechanism of action, by considering the recorded clinical trial failure rates.
• Observe the potential growth patterns expected for the asthma market over the forecast period, and identify which countries are expected to contribute the most to this growth.

Spanning over 106 pages, 21 tables and 49 figures “Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth” report provide Detailed analysis of the asthma pipeline, including, among other parameters, details of drug distribution by phase, molecule type and mechanism of action. The asthma clinical trial landscape is then analyzed, with a particular emphasis on failure rates across phases as well as trends in clinical trial size and duration, and by mechanism of action. This section also includes single-product forecasts for the most promising pipeline drugs.

In addition to covering the Marketed Products, Asthma Pipeline, Market Forecast to 2019, Strategic Consolidations.

For more information visit: http://www.marketresearchreports.com/gbi-research/asthma-therapeutics-market-2019-breakthrough-biologics-enhance-treatment-severe-asthma

Find all Healthcare reports under a single page

MarketResearchReports.com: Computed Tomography Systems Market to 2019 - Lower Radiation Dose and Improved Workflow in Advanced CT Systems to Increase Adoption Rates, New Report Launched

Computed Tomography Systems Market to 2019 Lower Radiation Dose and Improved Workflow in Advanced CT Systems to Increase Adoption Rates report looks at the market, competitive landscape, and trends for three computed tomography systems segments: high slice computed tomography systems, mid slice computed tomography systems and low slice computed tomography systems.

Report also reviews the competitive landscape and the details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by publisher team of industry experts.

Scope

• Key geographies of the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil
• Information on market size for three computed tomography systems segments: high slice computed tomography systems, mid slice computed tomography systems and low slice computed tomography systems.
• Annualized market revenue data forecast to 2019 and company share data for 2012
• Qualitative analysis of key trends in the computed tomography systems market
• Information on the leading market players, the competitive landscape, and the leading technologies
• Information on key players: GE Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Philips Healthcare, Hitachi Medical Corporation and Neusoft Medical Systems Co., Ltd.

Reasons to buy

• Develop business strategies by understanding the trends and developments driving the global computed tomography systems market
• Design and enhance your product development, marketing, and sales strategies
• Exploit M&A opportunities by identifying the market players with the most innovative pipelines
• Develop market-entry and market-expansion strategies
• Identify the key players best positioned to take advantage of emerging-market opportunities
• Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return
• Identify, understand and capitalize on the next big thing in the computed tomography systems market landscape
• Make more informed business decisions from the insightful and in-depth analysis of the global computed tomography systems market and the factors shaping it

Spanning over 85 pages, 49 tables and 45 figures “Computed Tomography Systems Market to 2019 - Lower Radiation Dose and Improved Workflow in Advanced CT Systems to Increase Adoption Rates” report provides comprehensive information on the key trends affecting these segments and analyzes the market dynamics. For more information visit: http://www.marketresearchreports.com/gbi-research/computed-tomography-systems-market-2019-lower-radiation-dose-and-improved-workflow

In addition to covering the Computed Tomography Systems: Overview, Computed Tomography Systems: Market Characterization, Global Computed Tomography Systems Market: Segment Analysis and Forecasts, Global Computed Tomography Systems Market: Country Analysis and Forecasts, Global Computed Tomography Systems Market: Reimbursement Trends, Global Computed Tomography Systems Market: Distribution System, Global Computed Tomography Systems Market: Company Profiles, Global Computed Tomography Systems Market: Product Pipeline Analysis, Global Computed Tomography Systems Market: Consolidation Landscape. The report covers 6 companies - GE Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Philips Healthcare, Hitachi Medical Corporation and Neusoft Medical Systems Co., Ltd.

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: Mammography Equipment Market to 2019 - Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection, New Report Launched

Mammography Equipment Market to 2019 - Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection report looks at the market, competitive landscape, and trends for the two mammography equipment market segments: digital radiography mammography equipment and film-screen mammography equipment.

The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important Merger and Acquisition (M&A) deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by publisher team of industry experts.

Scope

• Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil
• Information on market size for the two mammography equipment market segments: full-field digital mammography equipment and film-screen mammography equipment
• Annualized market revenue data forecast to 2019 and company share data for 2012
• Qualitative analysis of key trends in the mammography equipment market
• Information on the competitive landscape, and the leading technologies of key players: Hologic, GE Healthcare, Siemens Healthcare, Philips Healthcare and FujiFilm Holdings Corporation
• Information on reimbursement trends and market access for key countries

Reasons to buy

• Develop business strategies by understanding the trends and developments driving the global mammography equipment market
• Design and enhance your product development, marketing, and sales strategies
• Exploit M&A opportunities by identifying the market players with the most innovative pipelines
• Develop market-entry and market-expansion strategies
• Identify the key players best-positioned to take advantage of the emerging market opportunities
• Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return
• Identify, understand and capitalize on the next big thing in the mammography equipment market landscape
• Make more informed business decisions from insightful and in-depth analysis of the global mammography equipment market and the factors shaping it

Spanning over 79 pages, 38 tables and 39 figures “Mammography Equipment Market to 2019 - Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection” report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. For more information visit: http://www.marketresearchreports.com/gbi-research/mammography-equipment-market-2019-growth-driven-technical-advances-digital-radiography

In addition to covering the Market Access – Regulatory Process, Distribution and Supply Chain, Reimbursement Trends, Global Mammography Equipment Market: Market Characterization, Global Mammography Equipment Market: Country Analysis, Global Mammography Equipment Market: Cost and Efficacy Analysis, Global Mammography Equipment Market: Comparison of DR mammography systems, Global Mammography Equipment Market: Key Company Profiles, Global Mammography Equipment Market: Pipeline Analysis, Global Mammography Equipment Market: Consolidation Landscape. The report covers 5 companies Hologic, Inc., GE Healthcare, Siemens Healthcare, Fujifilm Holdings Corporation and Philips Healthcare.

Find all Medical Devices reports under a single page

MarketResearchReports.com: Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics (Antibodies, Antibiotics, Anti-Infectives), New Report Launched

Novel Prophylactic and Therapeutic Approaches to Manage Staphylococcus aureus (S. aureus) Infections

Staphylococcus aureus disease is the leading cause of surgical site infections and infections that arise within hospital Intensive Care Units. Despite a clear and growing medical need, the pipeline for new antibiotics is drying up. Many pharmaceutical companies have abandoned antimicrobial research. In the meantime, bacteria are becoming more resistant to current antibiotics, with fewer new drugs being approved.

The present Competitive Intelligence Report about prophylaxis and therapy of S. aureus infections provides a competitor evaluation in the field of new molecules for prevention or treatment of Staphylococcus aureus infections as of October 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

Staphylococcal aureus infections represent an enormous burden to public health systems. Traditionally restricted to the hospital setting as nosocomial infections, highly virulent strains have recently emerged in outside healthcare settings. Together with the increasing resistance to many antibacterials in a wide variety of staphylococcal strains, development of vaccines or specific and potent therapies for staphylococcal diseases raised increasing interest . Finding a vaccine for staphylococci is not trivial, as protective immunity to staphylococcal infections does not appear to exist at a significant degree. Promising results from novel approaches based on the combination of systematically selected antigens have been reported.

Passive immunotherapy with monoclonal therapeutic antibodies against S.aureus is another means to approach specific therapy of staphylococcal. While anti-staphylococcal purified polyclonal immunoglobulins are not recommended for prevention of staphylococcal infections in preterm or VLBW neonates, monoclonal antibodies are currently emerging and are in early development. Although not specific, bactericidal proteins and peptides with activity against S. aureus are in preclinical and clinical development. More targeted and improved antibiotics are also in development.

The report lists company-specific R&D pipelines of S. aureus vaccines and therapeutics. Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Spanning over 92 pages, “Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics (Antibodies, Antibiotics, Anti-Infectives)” report includes a compilation of currently active projects in research and development of antibodies, proteins, peptides, vaccines and small molecules for prevention and  treatment of Staphylococcus aureus infections. For more information visit:  http://www.marketresearchreports.com/la-merie-publishing/competitor-analysis-staphylococcus-aureus-vaccines-and-therapeutics-antibodies

In addition to covering the S. aureus Vaccines, S. aureus Antibodies, S. aureus Antibiotics, S. aureus Antiseptics & Anti-Infectives, Corporate S. aureus Vaccines & Therapeutics R&D Pipelines.

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: The Engineered T-Cell Receptor in Fusion Proteins, Antibodies and Cells: Emerging Opportunities for the Biopharmaceutical Industry, New Report Launched

A comparative analysis and assessment of TCR technologies, pipelines and companies from an industry perspective

Therapeutic monoclonal antibodies have become an increasingly successful treatment modality with sales of US$ 65 bln in the year 2012 and with an average (continuous) annual growth rate from 2006 to 2012 of 18.9%. While antibody technologies are steadily evolving, the spectrum of druggable targets for monoclonal antibodies has remained limited to extracellular antigens, albeit including proteins, carbohydrates and glycolipids.

Access to druggable, IP-protected and validated new targets is a major bottleneck in the biopharmaceutical industry. Technologies which can deliver both new targets and the corresponding treatment modality, can expect significant financial acknowledgement.

The T-cell receptor (TCR) has recently emerged as a means to target peptide antigens derived from intracellular proteins, however, in a major histocompatibility complex (MHC)-restricted manner.  The first companies have overcome significant technical hurdles in putting together a library of viable new TCR-targeted antigens and establish the corresponding standardized protein- and cell-based therapeutic frameworks.

This report entitled, “The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry” published in Ocotber 2013 describes chances and pitfals in exploiting the opportunities which offers the engineered T-cell receptor as integral part of fusion proteins, antibodies and cellular products. The key success factors are highlighted, the technical challenges described and solutions presented.

Benefits from the report:

• Identify players in the field, from industry and academia;
• Find out which TCR technologies are valued by Big Pharma and Biotech;
• Understand the value of intracellular antigens targeted by the TCR;
• Recognize the challenges of TCR-based therapeutics and their solutions;
• Learn which TCR-based therapeutics are attractive for partnering;
• Find out which TCR therapeutic approaches are not yet tapped.

Spanning over 84 pages and 5 table, “The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry” report provides information on market overview, drivers and challenge, competition and key trends.

In addition to covering the The T-Cell Receptor, TCR Fusion Proteins, TCR-Like (TCRL) Antibodies, TCR-Transfected T-Cells, Artificial TCR T-Cells: Chimeric Antigen Receptor (CAR) T-Cells, Tumor-Infiltrating Lymphocytes (TILs), Opportunity Analysis for TCR-based Products and Technologies, Corporate R&D Pipelines.

For more information visit: http://www.marketresearchreports.com/la-merie-publishing/engineered-t-cell-receptor-fusion-proteins-antibodies-cells-emerging

Find all Therapeutic reports under a single page